Updated COVID-19 Vaccines Show Continued Efficacy Against Severe Illness and Cardiac Complications

Recent research confirms that the latest COVID-19 vaccine formulations for 2024-2025 effectively reduce the risk of severe disease, hospitalizations, and critical illness. One study specifically noted a significant reduction in COVID-associated major adverse cardiovascular events among vaccinated veterans. These benefits are particularly pronounced in older and higher-risk individuals, though protection may diminish after approximately six months.